Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8586023 Cell capable of expressing exogenous GITR ligand

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
September 11, 2009
Date of Patent
November 19, 2013
Patent Application Number
13062999
Patent Citations Received
‌
US Patent 12083121 Substituted piperazines as KRAS G12C inhibitors
0
‌
US Patent 12006356 Anti-CCT5 binding molecules and chimeric antigen receptors comprising the same
0
‌
US Patent 12018073 Antagonists targeting the TGF-β pathway
0
‌
US Patent 11667613 Antiviral pyrazolopyridinone compounds
0
‌
US Patent 11667716 Bispecific antagonist comprising a LAG-3 binding domain
0
‌
US Patent 11766436 KRAS G12C inhibitors and methods of using the same
‌
US Patent 11851493 Trispecific antagonists
0
‌
US Patent 11905281 KRAS G12C inhibitors and methods of using the same
0
‌
US Patent 11918584 Combination therapy including a KRAS
0
‌
US Patent 11944647 Articles of manufacture and methods for treatment using adoptive cell therapy
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8586023
Patent Primary Examiner
‌
Marianne P Allen

Find more entities like US Patent 8586023 Cell capable of expressing exogenous GITR ligand

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo